Serendipitous synergism - an exceptional response to treatment with pembrolizumab in the course of a natural immunovirotherapy: a case report and review of the literature.

Saved in:
Bibliographic Details
Title: Serendipitous synergism - an exceptional response to treatment with pembrolizumab in the course of a natural immunovirotherapy: a case report and review of the literature.
Authors: Khoury LM; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Burcher KM; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Ng RT; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Song AH; Department of Internal Medicine, Section on Hematology and Oncology, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Chang MJ; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Gavrila E; Wake Forest University School of Medicine, Winston-Salem, NC, USA., Bloomer CH; Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Robinson MB; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA., Kouri BE; Department of Radiology, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Waltonen JD; Department of Otolaryngology, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Bunch PM; Department of Radiology, Wake Forest University School of Medicine, Winston-Salem, NC, USA., Lauer UM; Department of Internal Medicine VIII, Medical Oncology and Pneumology, University Hospital Tuebingen, Germany German Cancer Research Center (DKFZ), Tuebingen, Germany., Porosnicu M; Department of Internal Medicine, Section on Hematology and Oncology, Wake Forest University School of Medicine, Medical Center Blvd, Winston-Salem, NC 27101-4135, USA.; Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem, NC, USA.
Source: Therapeutic advances in medical oncology [Ther Adv Med Oncol] 2022 Oct 20; Vol. 14, pp. 17588359221122729. Date of Electronic Publication: 2022 Oct 20 (Print Publication: 2022).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1758-8340
DOI:10.1177/17588359221122729